Astellas Pharma Inc. (TYO:4503)
Japan flag Japan · Delayed Price · Currency is JPY
2,612.00
+4.50 (0.17%)
Apr 7, 2026, 3:30 PM JST

Astellas Pharma Ratios and Metrics

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
4,671,1032,589,3902,946,7733,381,4093,519,7383,161,421
Market Cap Growth
80.46%-12.13%-12.85%-3.93%11.33%1.80%
Enterprise Value
5,143,8273,324,8893,565,9263,003,9713,170,1892,856,153
Last Close Price
2607.501391.081508.431665.161636.751420.04
PE Ratio
14.5551.03172.8834.2628.3726.22
Forward PE
14.5818.7321.0615.8716.5015.21
PS Ratio
2.271.351.842.232.722.53
PB Ratio
2.651.711.852.242.412.28
P/TBV Ratio
16.99--5.486.597.02
P/FCF Ratio
11.4816.4421.9211.6115.5311.48
P/OCF Ratio
10.2013.3117.0910.3213.6710.30
PEG Ratio
0.240.171.480.680.702.44
EV/Sales Ratio
2.501.742.221.982.452.29
EV/EBITDA Ratio
8.477.1912.638.9010.648.83
EV/EBIT Ratio
12.3912.6228.6212.9714.5311.38
EV/FCF Ratio
12.6421.1126.5310.3113.9810.37
Debt / Equity Ratio
0.410.620.630.140.150.20
Debt / EBITDA Ratio
1.192.033.570.610.720.86
Debt / FCF Ratio
1.785.957.500.700.941.01
Net Debt / Equity Ratio
0.270.500.42-0.11-0.07-0.03
Net Debt / EBITDA Ratio
0.771.622.38-0.51-0.34-0.15
Net Debt / FCF Ratio
1.164.755.00-0.59-0.45-0.17
Asset Turnover
0.580.550.530.630.560.54
Inventory Turnover
1.271.281.381.761.601.56
Quick Ratio
0.790.790.691.131.051.15
Current Ratio
1.091.130.931.451.341.47
Return on Equity (ROE)
19.81%3.26%1.10%6.65%8.72%9.01%
Return on Assets (ROA)
7.38%4.77%2.58%6.05%5.92%6.83%
Return on Invested Capital (ROIC)
16.07%11.63%4.72%12.83%12.80%15.28%
Return on Capital Employed (ROCE)
18.30%11.60%5.50%13.40%13.30%14.90%
Earnings Yield
6.91%1.96%0.58%2.92%3.52%3.81%
FCF Yield
8.71%6.08%4.56%8.62%6.44%8.71%
Dividend Yield
3.02%5.32%4.64%3.60%3.06%2.96%
Payout Ratio
42.15%254.19%684.38%101.66%68.69%63.15%
Buyback Yield / Dilution
-0.64%0.14%1.39%1.38%0.41%1.03%
Total Shareholder Return
2.38%5.46%6.03%4.98%3.46%3.99%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.